patvann/cms122v6-diabetes-hemoglobin-a1c-poor-control
patvann/cms122v6-diabetes-hemoglobin-a1c-poor-control
Target Population
Designed for patients aged 18-75 who have been diagnosed with Type 1 or Type 2 diabetes. Targeting inidividuals whose most recent Hemoglobin A1c (HbA1c) level is above 9.0% or who do not have a documented HbA1c test result within the measurement period.
Recommendations
-
For Patients Without Recent HbA1c Testing: Order an HbA1c test if one has not been performed recently.
-
For Patients With Elevated HbA1c Levels: Discuss lifestyle modifications and medication compliance.
Importance
High HbA1c levels (> 9.0%) indicate poor glycemic control, which significantly increases the risk of these complications. By monitoring and managing HbA1c levels effectively, this protocol aims to improve patient outcomes and reduce long-term healthcare costs associated with diabetes.
Conclusion
Identifying patients with poor glycemic control, helps to ensure timely interventions that can mitigate the risk of severe complications.
Resources
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
As the seventh leading cause of death in the U.S., diabetes kills approximately 75,000 people a year (CDC FastStats 2015). Diabetes is a group of diseases marked by high blood glucose levels, resulting from the body's inability to produce or use insulin (CDC Statistics 2014, ADA Basics 2013). People with diabetes are at increased risk of serious health complications including vision loss, heart disease, stroke, kidney failure, amputation of toes, feet or legs, and premature death. (CDC Fact Sheet 2014).
In 2012, diabetes cost the U.S. an estimated $245 billion: $176 billion in direct medical costs and $69 billion in reduced productivity. This is a 41 percent increase from the estimated $174 billion spent on diabetes in 2007 (ADA Economic 2013).
Reducing A1c blood level results by 1 percentage point (eg, from 8.0 percent to 7.0 percent) helps reduce the risk of microvascular complications (eye, kidney and nerve diseases) by as much as 40 percent (CDC Estimates 2011).
View Resource Paper